The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Acquired hemophilia A: Updated review of evidence and treatment guidance
Open accessAbstract
Acquired hemophilia A (AHA) is a rare disease resulting from autoantibodies (inhibitors) against endogenous factor VIII (FVIII) that leads to bleeding, which is often spontaneous and severe. AHA tends to occur in elderly patients with comorbidities and is associated with high mortality risk from underlying comorbidities, bleeding, or treatment complications. Treatment, which consists of hemostatic management and eradication of the inhibitors, can be challenging to manage. Few data are available to guide the management of AHA‐related bleeding and eradication of the disease‐causing antibodies. Endorsed by the Hemostasis and Thrombosis Research Society of North America, an international panel of experts in AHA analyzed key questions, reviewed the literature, weighed the evidence and formed a consensus to update existing guidelines. AHA is likely underdiagnosed and misdiagnosed in real‐world clinical practice. Recommendations for the management of AHA are summarized here based on the available data, integrated with the clinical experience of panel participants.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Survey of 215 Non-Hemophilic Patients with Inhibitors to Factor VIII
Green, D., & Lechner, K. (1981) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650169 · Cited by 773
Collins, P. W., Hirsch, S., Baglin, T. P., Dolan, G., Hanley, J., Makris, M., Keeling, D. M., Liesner, R., Brown, S. A., Hay, C. R. M., et al. (2007) · Blood · doi:10.1182/blood-2006-06-029850 · Cited by 749
Self-citationGuidelines on the investigation and management of antiphospholipid syndrome
Keeling, D., Mackie, I., Moore, G. W., Greer, I. A., Greaves, M., & British Committee for Standards in Haematology (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2012.09037.x · Cited by 740
KNOEBL, P., MARCO, P., BAUDO, F., COLLINS, P., HUTH‐KÜHNE, A., NEMES, L., PELLEGRINI, F., TENGBORN, L., & LÉVESQUE, H. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2012.04654.x · Cited by 539
Self-citationAcquired Haemophilia: Review and Meta‐Analysis Focused on Therapy and Prognostic Factors
Delgado, J., Jimenez‐Yuste, V., Hernandez‐Navarro, F., & Villar, A. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04162.x · Cited by 469
International recommendations on the diagnosis and treatment of patients with acquired hemophilia A
Huth-Kuhne, A., Baudo, F., Collins, P., Ingerslev, J., Kessler, C. M., Levesque, H., Castellano, M. E. M., Shima, M., & St-Louis, J. (2009) · Haematologica · doi:10.3324/haematol.2008.001743 · Cited by 433
Self-citationBaudo, F., Collins, P., Huth-Kühne, A., Lévesque, H., Marco, P., Nemes, L., Pellegrini, F., Tengborn, L., & Knoebl, P. (2012) · Blood · doi:10.1182/blood-2012-02-408930 · Cited by 386
Self-citationCollins, P., Baudo, F., Knoebl, P., Lévesque, H., Nemes, L., Pellegrini, F., Marco, P., Tengborn, L., & Huth-Kühne, A. (2012) · Blood · doi:10.1182/blood-2012-02-409185 · Cited by 355
Self-citationTiede, A., Klamroth, R., Scharf, R. E., Trappe, R. U., Holstein, K., Huth-Kühne, A., Gottstein, S., Geisen, U., Schenk, J., Scholz, U., et al. (2015) · Blood · doi:10.1182/blood-2014-07-587089 · Cited by 295
Self-citationDiagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition)
Collins, P. W., Chalmers, E., Hart, D. P., Liesner, R., Rangarajan, S., Talks, K., Williams, M., & Hay, C. R. (2013) · British Journal of Haematology · doi:10.1111/bjh.12091 · Cited by 213
Self-citationAcquired Factor VIII Inhibitors: Pathophysiology and Treatment
Ma, A. D., & Carrizosa, D. (2006) · Hematology · doi:10.1182/asheducation-2006.1.432 · Cited by 177
Kruse‐Jarres, R., St‐Louis, J., Greist, A., Shapiro, A., Smith, H., Chowdary, P., Drebes, A., Gomperts, E., Bourgeois, C., Mo, M., et al. (2015) · Haemophilia · doi:10.1111/hae.12627 · Cited by 176
Self-citationBorg, J. Y., Guillet, B., Le Cam‐Duchez, V., Goudemand, J., Lévesque, H., & The SACHA Study Group (2013) · Haemophilia · doi:10.1111/hae.12138 · Cited by 159
Tengborn, L., Baudo, F., Huth‐Kühne, A., Knöbl, P., Levesque, H., Marco, P., Pellegrini, F., Nemes, L., Collins, P. W., & on behalf of the EACH2 registry contributors (2012) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2012.03469.x · Cited by 149
Self-citationHauser, I. J., Schneider, B., & Lechner, K. (1995) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1651666 · Cited by 149
Treatment of acquired haemophilia with recombinant activated FVII: a critical appraisal
Sumner, M., Geldziler, B., PEDERSEN, M., & Seremetis, S. V. (2007) · Haemophilia · doi:10.1111/j.1365-2516.2007.01474.x · Cited by 136
Hauser, I. J., Schneider, B., & Lechner, K. (1995) · PubMed · Cited by 135
Combination Immunosuppressive Therapy after Factor VIII Infusion for Acquired Factor VIII Inhibitor
Lian, E., Larcada, A. F., & Chiu, A. Y.-Z. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-110-10-774 · Cited by 122
Zeitler, H., Ulrich-Merzenich, G. S., Heß, L., Konsek, E., Unkrig, C., Walger, P., Vetter, H., & Brackmann, H. (2004) · Blood · doi:10.1182/blood-2004-05-1811 · Cited by 120
Laboratory Diagnosis of Acquired Hemophilia A: Limitations, Consequences, and Challenges
Werwitzke, S., Scharf, R., & Tiede, A. (2014) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0034-1390004 · Cited by 114 · cited 17×
“IST is recommended in all adult patients with AHA.”
BackgroundSelf-citationHvas, A., Sørensen, H. T., Norengaard, L., Christiansen, K., Ingerslev, J., & Sørensen, B. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02755.x · Cited by 107
The prognosis and treatment of acquired hemophilia: a systematic review and meta-analysis
Bitting, R. L., Bent, S., Li, Y., & Kohlwes, J. (2009) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0b013e32832ca388 · Cited by 94
Postpartum acquired factor VIII inhibitors: Results of a survey
Solymoss, S. (1998) · American Journal of Hematology · doi:10.1002/(sici)1096-8652(199809)59:1<1::aid-ajh1>3.0.co;2-t · Cited by 91
Coller, B., Hultin, M., Hoyer, L., Miller, F. W., Dobbs, J., Dosik, M., & Berger, E. R. (1981) · Blood · doi:10.1182/blood.v58.3.619.619 · Cited by 85
New protocol for immune tolerance induction in acquired hemophilia.
Nemes, L., & Pitlik, E. (2000) · PubMed · Cited by 75
Tiede, A., Hofbauer, C. J., Werwitzke, S., Knöbl, P., Gottstein, S., Scharf, R. E., Heinz, J., Groß, J., Holstein, K., Dobbelstein, C. E., et al. (2016) · Blood · doi:10.1182/blood-2015-09-672774 · Cited by 72
Self-citationAcquired hemophilia in pediatrics: A systematic review
Franchini, M., Zaffanello, M., & Lippi, G. (2010) · Pediatric Blood & Cancer · doi:10.1002/pbc.22657 · Cited by 71
Parallel use of by‐passing agents in haemophilia with inhibitors: a critical review
Ingerslev, J., & Sørensen, B. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08854.x · Cited by 70
HOLMSTRÖM, M., Tran, H. T. T., & Holme, P. A. (2012) · Haemophilia · doi:10.1111/j.1365-2516.2012.02748.x · Cited by 64
Werwitzke, S., Geisen, U., Nowak‐Göttl, U., Eichler, H., Stephan, B., Scholz, U., Holstein, K., Klamroth, R., Knöbl, P., Huth‐Kühne, A., et al. (2016) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13304 · Cited by 58
Self-citationGenetic markers in acquired haemophilia
Oldenburg, J., Zeitler, H.-J., & Pavlova, A. (2010) · Haemophilia · doi:10.1111/j.1365-2516.2010.02259.x · Cited by 56
Schulman, S., Langevitz, P., Livneh, A., Martinowitz, U. P., Seligsohn, U., & Varon, D. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650581 · Cited by 54
Therapeutic challenges in acquired factor VIII deficiency
Collins, P. W. (2012) · Hematology · doi:10.1182/asheducation.v2012.1.369.3798356 · Cited by 54
Self-citationThe use of desmopressin in acquired haemophilia A: a systematic review.
Franchini, M., & Lippi, G. (2011) · Europe PMC (PubMed Central) · doi:10.2450/2011.0113-10 · Cited by 39
Cyclosporin treatment of a woman with acquired haemophilia due to factor VIII:C inhibitor
Pfliegler, G., Boda, Z., Hársfalvi, J., Flóra-Nagy, M., Sari, B. M. M., Pecze, K., & Rák, K. (1989) · Postgraduate Medical Journal · doi:10.1136/pgmj.65.764.400 · Cited by 36
Aquired factor VIII inhibitor treated with cyclophosphamide, vincristine, and prednisone
Lian, E., Villar, M. J., Noy, L. I., & Dayao, Z. R. (2002) · American Journal of Hematology · doi:10.1002/ajh.10070 · Cited by 35
Successful treatment of acquired factor VIII inhibitor with cyclosporin
Au, W. Y., Lam, C. C. K., & Kwong, Y. (2004) · Haemophilia · doi:10.1046/j.1365-2516.2003.00837.x · Cited by 35
Postpartum acquired haemophilia: a single centre experience with rituximab
Dedeken, L., ST‐LOUIS, J., Demers, C., Meilleur, C. E., & Rivard, G. (2009) · Haemophilia · doi:10.1111/j.1365-2516.2009.02008.x · Cited by 25
Thrombelastographic monitoring of recombinant factor VIIa in acquired haemophilia
Dehmel, H., Werwitzke, S., Trummer, A., Ganser, A., & Tiede, A. (2008) · Haemophilia · doi:10.1111/j.1365-2516.2008.01759.x · Cited by 24
Self-citationPardos‐Gea, J., Altisent, C., Parra, R., Vilardell, M., & Ordi‐Ros, J. (2012) · Haemophilia · doi:10.1111/j.1365-2516.2012.02772.x · Cited by 21
Batty, P. A., Moore, G. W., Platton, S., Maloney, J., Palmer, B., Bowles, L., Pasi, J., Rangarajan, S., & Hart, D. P. (2015) · Thrombosis and Haemostasis · doi:10.1160/th14-12-1062 · Cited by 19
A Simplified Algorithm for the Laboratory Detection of Lupus Anticoagulants
Zhang, L., Whitis, J. G., Embry, M. B., & Hollensead, S. C. (2005) · American Journal of Clinical Pathology · doi:10.1309/6hye47508gwttc4e · Cited by 12
Cited by
(2022) · Blood transfusion · doi:10.2450/2022.0238-21 · Cited by 22
“In the presence of haemorrhagic events, the aim of treatment is primarily to control the acute bleeding quickly but, at the same time, to eradicate the inhibitor, minimising the risk of recurrent bleeding, which persists as long as the anti-FVIII inhibitor is present 7,8,10,30,31 .”
Saudi expert consensus on acquired hemophilia A diagnosis and management
Almomen, A. M., Alzahrani, H. A., AlSaeed, H. H., AlAseri, Z., Mady, A. F., & Owaidah, T. (2024) · Journal of Taibah University Medical Sciences · doi:10.1016/j.jtumed.2024.04.006 · Cited by 1
Metadata
- Authors
- Kruse‐Jarres, R., Kempton, C. L., Baudo, F., Collins, P. W., Knoebl, P., Leissinger, C. A., Tiede, A., & Kessler, C. M.
- Venue
- American Journal of Hematology
- Publisher
- Wiley
- Published
- 2017-06-05
- Volume
- 92
- Issue
- 7
- Pages
- 695-705
- ISSN
- 0361-8609 (ISSN-L)
- 1096-8652
- OpenAlex
- W2611005000
- Cited by
- 393
- References
- 42
- FWCI
- 21.90
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.